These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 11901763)
1. Effect of ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci formation in rat colon: in vitro potential role of intracellular Ca2+. Momen MA; Monden Y; Houchi H; Umemoto A J Med Invest; 2002 Feb; 49(1-2):67-73. PubMed ID: 11901763 [TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development. Wali RK; Stoiber D; Nguyen L; Hart J; Sitrin MD; Brasitus T; Bissonnette M Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1316-21. PubMed ID: 12433708 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats. Narisawa T; Fukaura Y; Terada K; Sekiguchi H J Exp Clin Cancer Res; 1999 Jun; 18(2):259-66. PubMed ID: 10464717 [TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057 [TBL] [Abstract][Full Text] [Related]
5. Effects of bile acids on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced aberrant crypt foci and DNA adduct formation in the rat colon. Ueyama Y; Monden Y; He XB; Lin CX; Momen MA; Mimura S; Umemoto A J Exp Clin Cancer Res; 2002 Dec; 21(4):577-83. PubMed ID: 12636105 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913 [TBL] [Abstract][Full Text] [Related]
7. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Raju J; Patlolla JM; Swamy MV; Rao CV Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of Centella asiatica on azoxymethane-induced aberrant crypt focus formation and carcinogenesis in the intestines of F344 rats. Bunpo P; Kataoka K; Arimochi H; Nakayama H; Kuwahara T; Bando Y; Izumi K; Vinitketkumnuen U; Ohnishi Y Food Chem Toxicol; 2004 Dec; 42(12):1987-97. PubMed ID: 15500935 [TBL] [Abstract][Full Text] [Related]
9. Preventive effect of fermented brown rice and rice bran against colon carcinogenesis in male F344 rats. Katyama M; Yoshimi N; Yamada Y; Sakata K; Kuno T; Yoshida K; Qiao Z; Vihn PQ; Iwasaki T; Kobayashi H; Mori H Oncol Rep; 2002; 9(4):817-22. PubMed ID: 12066215 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Wargovich MJ; Jimenez A; McKee K; Steele VE; Velasco M; Woods J; Price R; Gray K; Kelloff GJ Carcinogenesis; 2000 Jun; 21(6):1149-55. PubMed ID: 10837003 [TBL] [Abstract][Full Text] [Related]
11. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Magnuson BA; Carr I; Bird RP Cancer Res; 1993 Oct; 53(19):4499-504. PubMed ID: 8402621 [TBL] [Abstract][Full Text] [Related]
12. Effect of azoxymethane and curcumin on transcriptional levels of cyclooxygenase-1 and -2 during initiation of colon carcinogenesis. Kwon Y; Magnuson BA Scand J Gastroenterol; 2007 Jan; 42(1):72-80. PubMed ID: 17190766 [TBL] [Abstract][Full Text] [Related]
13. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis. Femia AP; Dolara P; Caderni G Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897 [TBL] [Abstract][Full Text] [Related]
14. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane. Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579 [TBL] [Abstract][Full Text] [Related]
15. Varying effect of dietary lipids and azoxymethane on early stages of colon carcinogenesis: enumeration of aberrant crypt foci and proliferative indices. Bird RP; Lafave LM Cancer Detect Prev; 1995; 19(4):308-15. PubMed ID: 7553672 [TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Earnest DL; Holubec H; Wali RK; Jolley CS; Bissonette M; Bhattacharyya AK; Roy H; Khare S; Brasitus TA Cancer Res; 1994 Oct; 54(19):5071-4. PubMed ID: 7923119 [TBL] [Abstract][Full Text] [Related]
17. Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps. Batta AK; Salen G; Holubec H; Brasitus TA; Alberts D; Earnest DL Cancer Res; 1998 Apr; 58(8):1684-7. PubMed ID: 9563483 [TBL] [Abstract][Full Text] [Related]
18. Effect of dietary apigenin on colonic ornithine decarboxylase activity, aberrant crypt foci formation, and tumorigenesis in different experimental models. Au A; Li B; Wang W; Roy H; Koehler K; Birt D Nutr Cancer; 2006; 54(2):243-51. PubMed ID: 16898869 [TBL] [Abstract][Full Text] [Related]
19. Effects of adlay on azoxymethane-induced colon carcinogenesis in rats. Shih CK; Chiang W; Kuo ML Food Chem Toxicol; 2004 Aug; 42(8):1339-47. PubMed ID: 15207385 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon. Chiampanichayakul S; Kataoka K; Arimochi H; Thumvijit S; Kuwahara T; Nakayama H; Vinitketkumnuen U; Ohnishi Y J Med Invest; 2001 Feb; 48(1-2):88-96. PubMed ID: 11286022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]